SCHEMBL27014751

SCHEMBL27014751

Brc1ccc2[nH]c3ccc4cccc(Br)c4c3c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.43
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
GABRA4 P48169 1/20 0.43
GABRE P78334 1/20 0.43
GABRA6 Q16445 1/20 0.43
GABRG1 Q8N1C3 1/20 0.43
GABRG3 Q99928 1/20 0.43
GABRQ Q9UN88 1/20 0.43
PIM3 Q86V86 1/20 0.41
MAPT P10636 2/20 0.41
CHUK O15111 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24549288 0.89 CDK4 (0.40) ARPIM3CCNB2CDK1CCNB1
SCHEMBL28474458 0.86 GABRP (0.50) ARGABRPGABRDGABRA1GABRB1
SCHEMBL29530429 0.86 GABRP (0.50) ARGABRPGABRDGABRA1GABRB1
SCHEMBL29655513 0.83 CDK4 (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20071605 0.83 CDK4 (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL22011591 0.82 CDK4 (0.55) ARGABRPGABRDGABRA1GABRB1
SCHEMBL27014754 0.82 CDK4 (0.57) CCNB2CDK1CCNB1CCNB3CDK4
SCHEMBL27014689 0.81 NOS1 (0.39) ARGABRPGABRDGABRA1GABRB1
SCHEMBL10044741 0.80 CDK4 (0.53) ARGABRPGABRDGABRA1GABRB1
SCHEMBL10019775 0.78 PIM3 (0.42) ARGABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023433-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, MANUFACTURING METHOD OF THE SAME AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023433-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, MANUFACTURING METHOD OF THE SAME AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, CYP2C9 AR 2061/4885GABRP 3070/4885GABRD 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.